Ca^{2 +} /calmodulin-dependent protein kinase II mediates apoptosis of P19 cells expressing human tau during neural differentiation with retinoic acid treatment

References

• L Buee, T Bussiere, V Buee-Scherrer, A Delacourte, and PR Hof. (2000). Tau protein isoforms, phosphorylation, and role in neurodegerative disorders. Brain Res Rev 33:95–130.
   PubMed Web of Science ®Google Scholar
• VMY Lee, M Goedert, and JQ Trojanowski. (2001). Neurogenerative tauopathies. Annu Rev Neurosci 24:1121–1159.
   PubMed Web of Science ®Google Scholar
• K Iqbal, AC Alonso, S Chen, MO Chohan, E El-Akkad, CX Gong, S Khatoon, B Li, F Liu, A Rahman, H Tanimukai, and I Grundke-Iqbal. (2005). Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739:198–210.
   PubMed Web of Science ®Google Scholar
• M Holzer, HP Holzapfel, D Zedlick, MK Bruckner, and T Arendt. (1994). Abnormally phosphorylated tau protein in Alzheimer's disease: Heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience 63:499–516.
   PubMed Web of Science ®Google Scholar
• M Rapoport, and A Ferreira. (2000). PD98059 prevents neurite degeneration induced by fibrillar β-amyliod in mature hippocampal neurons. J Neurochem 74:125–133.
   PubMed Web of Science ®Google Scholar
• N Shahani, S Subramaniam, T Wolf, C Tackenber, and R Brand. (2006). Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices. J Neurosci 26:6103–6114.
   PubMed Web of Science ®Google Scholar
• J Leschik, A Welzel, C Weissmann, A Eckert, and R Brandt. (2007). Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-β in cultures cortical neurons: Evidence that tau phosphorylation is the limiting factor in amyloid-β-induced cell death. J Neurochem 101:1303–1315.
   PubMed Web of Science ®Google Scholar
• WH Stoothoff, and GV Johsnon. (2005). Tau phosphorylation: Physiological and pathological consequences. Biochim Biophys Acta 1739:280–297.
   PubMed Web of Science ®Google Scholar
• K Ishiguro, A Shiratsuchi, S Sato, A Omori, M Arioka, S Kobayashi, T Uchida, and K Imahori. (1993). Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 325:167–172.
   PubMed Web of Science ®Google Scholar
• ET Lund, R McKenna, DB Evans, SK Sharma, and WR Mathews. (2001). Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry. J Neurochem 76:1221–1232.
   PubMed Web of Science ®Google Scholar
• CW Scott, RC Spreen, JL Herman, FP Chow, MD Davison, J Young, and CB Caputo. (1993). Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly. J Biol Chem 268:1166–1173.
   PubMed Web of Science ®Google Scholar
• B Steiner, EM Mandelkow, J Biernat, N Gustke, HE Meyer, B Schmidt, G Mieskes, HD Söling, D Drechsel, MW Kirschner, M Goedert, and E Mandelelkow. (1990). Phosphorylation of microtubule-associated protein tau: Identification of the site for Ca2+-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. EMBO J 9:3539–3544.
   PubMed Web of Science ®Google Scholar
• Y Yoshimura, T Ichinose, and T Yamauchi. (2003). Phosphorylation of tau protein to sites found in Alzheimer's disease brain is catalyzed by Ca2+/calmodukin-dependent protein kinase II as demonstrated tandem mass spectrometry. Neurosci Lett 353:185–188.
   PubMed Web of Science ®Google Scholar
• I Correas, J Diaz-Nido, and J Avila. (1992). Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain. J Biol Chem 267:15721–15728.
   PubMed Web of Science ®Google Scholar
• C Yoshizaki, M Tsukane, and T Yamauchi. (2004). Overexpression of tau leads to the stimulation of neurite outgrowth, the activation of caspase 3 activity, and accumulation and phosphorylation of tau in neuroblastoma cells on cAMP treatment. Neurosci Res 49:363–371.
   PubMed Web of Science ®Google Scholar
• M Tsukane, and T Yamauchi. (2006). Increase in apoptosis with neural differentiation and shortening of the lifespan of P19 cells overexpressing tau. Neurochem Int 48:243–254.
   PubMed Web of Science ®Google Scholar
• M Tsukane, C Yoshizaki, and T Yamauchi. (2007). Development and specific induction of apoptosis of cultured cell models overexpressing human tau during neural differentiation: Implication in Alzheimer's disease. Anal Biochem 360:114–122.
   PubMed Web of Science ®Google Scholar
• P Seubert, M Mawal-Dewan, R Barbort, R Jakes, M Goedert, GVW Johnson, JM Litersky, D Schenk, I Lieberburg, JQ Trojanowski, and VMY Lee. (1995). Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem 270:18917–18922.
   PubMed Web of Science ®Google Scholar
• DT Loo, A Copani, CJ Pike, ER Whittemore, AJ Walencewicz, and CW Cotman. (1993). Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951–7955.
   PubMed Web of Science ®Google Scholar
• G Smale, NR Nichols, DR Brady, CE Finch, and WE HortonJr. (1995). Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133:225–230.
   PubMed Web of Science ®Google Scholar
• M Hutton, CL Lendon, P Rizzu, M Baker1, S Froelich, H Houlden, S Pickering-Brown, S Chakraverty, A Isaacs, A Grover, J Hackett, J Adamson, S Lincoln, D Dickson, P Davies, RC Petersen, M Stevens, E de Graaff, E Wauters, J van Baren, M Hillebrand, M Joosse, JM Kwon, P Nowotny, LK Che, J Norton, JC Morris, LA Reed, J Trojanowski, H Basun, L Lannfelt, M Neystat, S Fahn, F Dark, T Tannenberg, PR Dodd, N Hayward, JBJ Kwok, PR Schofield, A Andreadis, J Snowden, D Craufurd, D Neary, F Owen, BA Oostra, J Hardy, A Goate, J van Swieten, D Mann, T Lynch, and P Heutink. (1998). Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702–705.
   PubMed Web of Science ®Google Scholar
• J Lewis, E McGowan, J Rockwood, H Melrose, P Nacharaju, M van Slegtenhorst, K Gwinn-Hardy, MP Murphy, M Baker, X Yu, K Duff, J Hardy, A Corral, WL Lin, SH Yen, DW Dickson, P Davies, and M Hutton. (2000). Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25:402–405.
   PubMed Web of Science ®Google Scholar
• S Le Corre, HW Klafki, N Plesnila, G Hubinger, A Obermeier, H Sahagun, B Monse, P Seneci, J Lewis, J Eriksen, C Zehr, M Yue, E McGowan, DW Dickson, M Hutton, and HM Roder. (2006). An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc Natl Acad Sci USA 103:9673–9678.
   PubMed Web of Science ®Google Scholar
• Y Takabayashi, E Planel, DH Chui, S Sato, T Miyasaka, N Sahara, M Maruyama, N Kikuchi, K Yoshioka, R Rivka, and A Takashima. (2006). c-jun N-terminal kinase hyperphosphorylates R406W tau at the PHF-1 site during mitosis. FASEB J 20:762–764.
   PubMed Web of Science ®Google Scholar
• B Allen, E Ingram, M Takao, MJ Smith, R Jakes, K Virdee, H Yoshida, H Yoshida, M Holzer, M Craxton, PC Emson, C Atzori, A Migheli, RA Crowther, B Ghetti, MG Spilantini, and M Goedert. (2002). Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 22:9340–9351.
   PubMed Web of Science ®Google Scholar
• J Hardy, K Duff, KG Hardy, J Perez-Tur, and M Hutton. (1998). Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau. Nat Neurosci 1:355–358.
   PubMed Web of Science ®Google Scholar
• EM Jones-Villeneuv, MA Rudnucki, JF Harris, and MW McBurney. (1983). Retinoic acid-induced neural differentiation of embryonal carcinoma cells. Mol Cell Biol 3:2271–2279.
   PubMed Web of Science ®Google Scholar
• H Donai, T Murakami, T Amano, Y Sogawa, and T Yamauchi. (2000). Induction and alternative splicing of δ isoform of Ca2+/calmodulin-dependent protein kinase II during neural differentiation of P19 embryonal carcinoma cells and during brain development. Mol Brain Res 85:189–199.
   PubMedGoogle Scholar
• T Yamauchi. (2005). Neuronal Ca2+/calmodulin-dependnet protein kinase II—Discovery, progress in a quarter of a century, and perspective: Implication for learning and memory. Biol Pharm Bull 28:1342–1354.
   PubMed Web of Science ®Google Scholar
• DP Hanger, JC Betts, TLF Loviny, WP Blackstock, and BH Anderton. (1998). New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J Neurochem 71:2465–2476.
   PubMed Web of Science ®Google Scholar
• M Morishima-Kawashima, M Hasegawa, K Takio, M Suzuki, H Yoshida, K Titani, and Y Ihara. (1995). Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem 270:823–829.
   PubMed Web of Science ®Google Scholar
• A Watanabe, M Hasegawa, M Suzuki, K Takio, M Morishima-Kawashima, K Titani, T Arai, KS Kosik, and Y Ihara. (1993). In vivo phosphorylation sites in fetal and adult rat tau. J Biol Chem 268:25712–25717.
   PubMed Web of Science ®Google Scholar
• G Drewes, B Trinczek, S Illenberger, J Biernat, G Schmitt-Ulms, HE Meyer, EM Mandelkow, and E Mandelkow. (1995). Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at Alzheimer-specific serine 262. J Biol Chem 270:7679–7688.
   PubMed Web of Science ®Google Scholar
• TJ Singh, JZ Wang, M Novak, E Kontzekova, I Grundke-Iqubal, and K Iqubal. (1996). Calcium/calmodulin-dependent protein kinase II phosphorylates tau at Ser-262 but only partially inhibits its binding to microtubules. FEBS Lett 387:145–148.
   PubMed Web of Science ®Google Scholar
• J Takahashi, TD Palmer, and FH Gage. (1999). Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures. J Neurobiol 38:65–81.
   PubMedGoogle Scholar
• S Khatoon, I Grundke-Iqbal, and K Iqbal. (1992). Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: A radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem 59:750–753.
   PubMed Web of Science ®Google Scholar
• R Brandt, M Hundelt, and N Shahani. (2005). Tau alteration and neuronal degeneration in tauopathies: Mechanisms and models. Biochim Biophys Acta 1739:331–354.
   PubMed Web of Science ®Google Scholar
• TC Gamblin, F Chen, A Zambrano, A Abraha, S Lagalwar, AL Guillozet, M Lu, Y Fu, F Garcia-Sierra, N LaPointe, R Miller, RW Berry, LI Binder, and VL Cryns. (2003). Caspase cleavage of tau: Linking amyloid and neurofibirillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 100:10032–10037.
   PubMed Web of Science ®Google Scholar